英文摘要 |
The renowned Chinese pharmacologist Li Shizhen (1518-1593) stated in his Compendium of Materia Medica that danggui (often rendered as Chinese angelica) was the essential medicine for women. Literarily, the Chinese character “dang” means “should” and “gui,” “to return.” Women were expected to be married by their late teens and their natal families were considered temporary dwelling place before they could “return” to their permanent homes, i.e., their husbands’ households. Li Shizhen, citing the classical notion, claimed that danggui, with its function of replenishing the blood, was essential to women’s reproductive power, and therefore acquired the name of “should return.” Danggui has been perceived as important to women’s health till this day, but a survey from Chinese antiquity onward shows diverse images and varied functions. Since the name carries the connotation of summoning someone, the plant was often used as a gift in the socio-political networking of early imperial China. It was first noted in medical texts as being effective in clearing clogged blood, and appeared in historical documents in the third century for its efficacy in soothing headaches. When it was applied on women, it was more often enlisted to help smooth deliveries than to enhance conception, and was hardly used as a drug for menstrual regulation in early medical recipes. Between the fifth and the thirteenth centuries, however, Chinese gynecology was gradually established on a gendered body view that saw the yin-blood as women’s constituent (versus the yang-essence as men’s). It was during this period that danggui began to assume the role of women’s medicine. From the tenth century onward, danggui was increasingly included in medical recipes for women of all ages, from menarche, postpartum to menopausal healthcare. This article traces the shifting and growing knowledge of danggui throughout Chinese history in the context of an evolving body view. It is reported that danggui was introduced to Europe, extracted to produce menstrual stimuli, eumenol, and sold back to China in the early twentieth century. Hopefully the current research will also serve as a point of departure for further case studies on international exchanges of materia medica. |